Frontier Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$8M Buy
52,199
+8,734
+20% +$1.34M 0.58% 44
2022
Q1
$7.27M Sell
43,465
-14,920
-26% -$2.5M 0.09% 43
2021
Q4
$7.91M Buy
58,385
+1,304
+2% +$177K 0.52% 40
2021
Q3
$6.16M Buy
57,081
+1,602
+3% +$173K 0.43% 50
2021
Q2
$6.25M Buy
55,479
+3,898
+8% +$439K 0.44% 45
2021
Q1
$5.58M Sell
51,581
-299
-0.6% -$32.4K 0.43% 46
2020
Q4
$5.56M Buy
51,880
+8,991
+21% +$963K 0.46% 46
2020
Q3
$3.76M Buy
42,889
+1,696
+4% +$149K 0.34% 55
2020
Q2
$4.04M Buy
41,193
+5,348
+15% +$525K 0.37% 51
2020
Q1
$2.73M Buy
35,845
+27,514
+330% +$2.1M 0.45% 62
2019
Q4
$738K Sell
8,331
-11,736
-58% -$1.04M 0.12% 136
2019
Q3
$1.52M Sell
20,067
-432
-2% -$32.7K 0.22% 95
2019
Q2
$1.49M Buy
20,499
+157
+0.8% +$11.4K 0.22% 94
2019
Q1
$1.64M Sell
20,342
-540
-3% -$43.5K 0.22% 97
2018
Q4
$1.93M Sell
20,882
-2,263
-10% -$209K 0.29% 82
2018
Q3
$2.19M Buy
23,145
+797
+4% +$75.4K 0.21% 78
2018
Q2
$2.07M Buy
22,348
+663
+3% +$61.4K 0.3% 81
2018
Q1
$2.05M Buy
21,685
+2,871
+15% +$272K 0.29% 86
2017
Q4
$1.82M Sell
18,814
-2,819
-13% -$273K 0.29% 82
2017
Q3
$1.92M Buy
21,633
+501
+2% +$44.5K 0.28% 93
2017
Q2
$1.53M Sell
21,132
-18
-0.1% -$1.31K 0.23% 104
2017
Q1
$1.38M Sell
21,150
-3,424
-14% -$223K 0.21% 122
2016
Q4
$1.54M Buy
24,574
+889
+4% +$55.7K 0.25% 109
2016
Q3
$1.49M Buy
23,685
+1,505
+7% +$94.9K 0.23% 104
2016
Q2
$1.37M Buy
22,180
+658
+3% +$40.7K 0.22% 110
2016
Q1
$1.23M Buy
21,522
+3,346
+18% +$191K 0.1% 115
2015
Q4
$1.08M Buy
18,176
+826
+5% +$48.9K 0.17% 124
2015
Q3
$944K Buy
17,350
+7,719
+80% +$420K 0.15% 138
2015
Q2
$647K Buy
+9,631
New +$647K 0.1% 173